background image

Press Releases

  Date Headline Download
 
12/01/2014 TissueGene, Inc. to Participate in the Buzz of BIO at the 2015 BIO CEO & Investor Conference
 
11/17/2014 TissueGene Receives Recommendations from FDA on Pathway to Phase 3 Trial of TG-C for Treatment of Osteoarthritis of the Knee
 
11/14/2012 TissueGene Completes Enrollment in U.S. Phase II Study of TG-C in Patients with Knee Osteoarthritis
 
05/19/2011 TissueGene Initiates Patient Enrollment for a Phase II Study of TG-C for Osteoarthritis of the Knee
 
02/08/2010 PharmaVigilant Supports TissueGene's Phase II Trial with Groundbreaking Imaging Capabilities
 
03/03/2009 TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee
 
10/03/2007 TissueGene Signs Contract to Locate on Johns Hopkins University – Montgomery County Campus
 
07/24/2006 TissueGene Initiates Phase I Clinical Trial with TG-C
 
05/18/2005 TissueGene, Inc. to Present at Windhover Information's ‘The Start-Up Forum 2005
 
04/19/2005 RheoGene Inc. and TissueGene Inc. Sign Collaborative Agreement for Bone Regeneration and Repair